Stocks
Organon Financial Statements (OGN) |
||||||||||
| Organonsmart-lab.ru | % | 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 31.12.2019 | 31.12.2020 | 21.03.2022 | 27.02.2023 | 26.02.2024 | 03.05.2024 | ||||
| Currency | USD | USD | USD | USD | USD | USD | ||||
| Financial report URL | ||||||||||
| Revenue, bln rub | ? | 7 777 | 8 096 | 6 304 | 6 174 | 6 263 | 4 727 | |||
| Operating Income, bln rub | 3 847 | 2 849 | 1 619 | 1 478 | 1 319 | 313.0 | ||||
| EBITDA, bln rub | ? | 4 180 | 3 006 | 1 814 | 1 690 | 1 553 | 986.4 | |||
| Net profit, bln rub | ? | 3 218 | 2 160 | 1 351 | 917.0 | 1 023 | 846.2 | |||
| OCF, bln rub | ? | 2 767 | 2 187 | 2 458 | 858.0 | 799.0 | 685.1 | |||
| CAPEX, bln rub | ? | 92.0 | 278.0 | 488.0 | 427.0 | 261.0 | 207.0 | |||
| FCF, bln rub | ? | 2 675 | 1 909 | 1 970 | 431.0 | 538.0 | 478.0 | |||
| Dividend payout, bln rub | 0.000 | 0.000 | 145.0 | 290.0 | 294.0 | 221.0 | ||||
| Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | ||||||
| Dividend payout ratio, % | 0.00% | 0.00% | 10.7% | 31.6% | 28.7% | 26.1% | ||||
| OPEX, bln rub | 1 663 | 1 970 | 2 111 | 2 175 | 2 429 | 1 858 | ||||
| Cost of production, bln rub | 2 274 | 3 347 | 2 382 | 2 294 | 2 515 | 1 936 | ||||
| R&D, bln rub | 220.0 | 304.0 | 443.0 | 471.0 | 536.0 | 399.1 | ||||
| Interest expenses, bln rub | 6.00 | 6.00 | 258.0 | 422.0 | 527.0 | 395.1 | ||||
| Assets, bln rub | 10 548 | 10 434 | 10 681 | 10 955 | 12 058 | 11.9 | ||||
| Net Assets, bln rub | ? | 7 035 | -820.0 | -1 508 | -892.0 | -70.0 | 0.048 | |||
| Debt, bln rub | 104.0 | 31.0 | 9 134 | 8 913 | 8 760 | 8.71 | ||||
| Cash, bln rub | 319.0 | 500.0 | 737.0 | 706.0 | 693.0 | 0.575 | ||||
| Net debt, bln rub | -215.0 | -469.0 | 8 397 | 8 207 | 8 067 | 8.14 | ||||
| Ordinary share price, rub | 30.5 | 27.9 | 14.4 | 30.5 | ||||||
| Number of ordinary shares, mln | 253.1 | 253.5 | 253.6 | 254.1 | 255.2 | 255.7 | ||||
| Market cap, bln rub | 0 | 0 | 7 721 | 7 097 | 3 681 | 7 799 | ||||
| EV, bln rub | ? | -215 | -469 | 16 118 | 15 304 | 11 748 | 7 807 | |||
| Book value, bln rub | 1 863 | -5 926 | -6 762 | -6 144 | -5 206 | -5 | ||||
| EPS, rub | ? | 12.7 | 8.52 | 5.33 | 3.61 | 4.01 | 3.31 | |||
| FCF/share, rub | 10.6 | 7.53 | 7.77 | 1.70 | 2.11 | 1.87 | ||||
| BV/share, rub | 7.36 | -23.4 | -26.7 | -24.2 | -20.4 | -0.02 | ||||
| EBITDA margin, % | ? | 53.7% | 37.1% | 28.8% | 27.4% | 24.8% | 20.9% | |||
| Net margin, % | ? | 41.4% | 26.7% | 21.4% | 14.9% | 16.3% | 17.9% | |||
| FCF yield, % | ? | 25.5% | 6.07% | 14.6% | 6.13% | |||||
| ROE, % | ? | 45.7% | -263.4% | -89.6% | -102.8% | -1 461% | 1 762 919% | |||
| ROA, % | ? | 30.5% | 20.7% | 12.6% | 8.37% | 8.48% | 7 116% | |||
| P/E | ? | 0.00 | 0.00 | 5.71 | 7.74 | 3.60 | 9.22 | |||
| P/FCF | 0.00 | 0.00 | 3.92 | 16.5 | 6.84 | 16.3 | ||||
| P/S | ? | 0.00 | 0.00 | 1.22 | 1.15 | 0.59 | 1.65 | |||
| P/BV | ? | 0.00 | 0.00 | -1.14 | -1.16 | -0.71 | -1 479 | |||
| EV/EBITDA | ? | -0.05 | -0.16 | 8.89 | 9.06 | 7.56 | 7.91 | |||
| Debt/EBITDA | -0.05 | -0.16 | 4.63 | 4.86 | 5.19 | 0.01 | ||||
| R&D/CAPEX, % | 239.1% | 109.4% | 90.8% | 110.3% | 205.4% | 192.8% | ||||
| CAPEX/Revenue, % | 1.18% | 3.43% | 7.74% | 6.92% | 4.17% | 4.38% | ||||
| Organon shareholders | ||||||||||
